P
Philip Green
Researcher at Columbia University Medical Center
Publications - 73
Citations - 2818
Philip Green is an academic researcher from Columbia University Medical Center. The author has contributed to research in topics: Valve replacement & Pulmonary embolism. The author has an hindex of 17, co-authored 67 publications receiving 2322 citations. Previous affiliations of Philip Green include Icahn School of Medicine at Mount Sinai & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Frailty Assessment in the Cardiovascular Care of Older Adults
Jonathan Afilalo,Karen P. Alexander,Michael J. Mack,Mathew S. Maurer,Philip Green,Larry A. Allen,Jeffrey J. Popma,Luigi Ferrucci,Daniel E. Forman +8 more
TL;DR: This work sought to synthesize the existing body of evidence and offer a perspective on how to integrate frailty into clinical practice and contribute valuable prognostic insights incremental to existing risk models and assists clinicians in defining optimal care pathways for their patients.
Journal ArticleDOI
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.
Philip Green,Abigail E. Woglom,Philippe Généreux,Benoit Daneault,Jean-Michel Paradis,Susan Schnell,Marian Hawkey,Mathew S. Maurer,Ajay J. Kirtane,Susheel Kodali,Jeffrey W. Moses,Martin B. Leon,Craig R. Smith,Mathew R. Williams +13 more
TL;DR: Frailty was not associated with increased periprocedural complications in patients selected as candidates to undergo TAVR but was associated withincreased 1-year mortality after TAVr, suggesting adequacy of the standard selection process for identifying patients at risk for periprosal complications after T AVR.
Journal ArticleDOI
Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention: The Residual SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) Score
Philippe Généreux,Tullio Palmerini,Adriano Caixeta,Gregg F. Rosner,Philip Green,Ovidiu Dressler,Ke Xu,Helen Parise,Roxana Mehran,Patrick W. Serruys,Gregg W. Stone +10 more
TL;DR: The rSS is useful to quantify and risk-stratify the degree and complexity of residual stenosis after percutaneous coronary intervention and is a strong independent predictor of all ischemic outcomes at 1 year, including all-cause mortality.
Journal ArticleDOI
Relation of Frailty to Outcomes After Transcatheter Aortic Valve Replacement (from the PARTNER Trial)
Philip Green,Suzanne V. Arnold,David Cohen,Ajay J. Kirtane,Susheel Kodali,David L. Brown,Charanjit S. Rihal,Ke Xu,Yang Lei,Marian Hawkey,Rebeca J. Kim,Maria Alu,Martin B. Leon,Michael J. Mack +13 more
TL;DR: Evaluating the prognostic value of frailty in older recipients of TAVR found that frail patients would experience a higher mortality rate and a higher likelihood of poor outcome 1 year after T AVR.
Journal ArticleDOI
Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial
Suzanne V. Arnold,Matthew R. Reynolds,Yang Lei,Elizabeth A. Magnuson,Ajay J. Kirtane,Susheel Kodali,Alan Zajarias,Vinod H. Thourani,Philip Green,Josep Rodés-Cabau,Nirat Beohar,Michael J. Mack,Martin B. Leon,David J. Cohen +13 more
TL;DR: Predictive models that can identify patients at high risk for a poor outcome after TAVR are developed and validated and may help guide treatment choices and offer patients realistic expectations of outcomes based on their presenting characteristics.